Aggressive Treatment Leads to Cures for Colon and Rectal Cancers

Colon and rectal cancer that is attached to critical body structures like the wall of the pelvis or important large veins has traditionally been considered not surgically treatable.  Patients have been offered palliative treatments designed to extend life or reduce symptoms, but the goal wasn’t cure. However, Mayo Clinic surgeons are now working together with teams…  Read More

Depression Can Hasten Cancer Death

Depressed patients with advanced cancer die sooner than those who are not depressed.  The more serious the depression, the more likely they are to die prematurely. Researchers in the United Kingdom screened cancer patients for depression using tests that were originally designed to diagnose depression in women after childbirth.  They looked at feelings of worthlessness and…  Read More

Circulating Tumor Cells Provide Information about Prognosis

The number of cancer tumor cells circulating in the bloodstream can provide information about prognosis and survival for people with metastatic colorectal cancer.  Measuring circulating tumor cells before beginning a treatment and then during treatment can help doctors decide if the therapy is working or whether cancer is getting worse. Tumor cells can be found in…  Read More

More Information on Better CRC Survival for Young Women

Another study has found better survival after a diagnosis of colorectal cancer in younger women. Among over two thousand colon and rectal cancer patients In Australia, women under the age of 50 had about half the risk of dying from colorectal cancer than men under 50. Better survival held true despite where the cancer was found,…  Read More

Xelox as Effective as FOLFOX after Colorectal Cancer Progresses

XELOX, as second-line therapy, was found to be as effective as the more commonly used FOLFOX treatment for patients whose cancer had already gotten worse on treatment with Camptosar® (irinotecan). XELOX combines an oral drug Xeloda® (capecitabine) with Eloxatin® (oxaliplatin).  FOLFOX uses an infusional schedule of 5FU and leucovorin. Researchers randomly compared XELOX to FOLFOX4 to…  Read More

Family History of Colorectal Cancer Improve Survival Chances

People with a family history of colon or rectal cancer may have a smaller risk of having the cancer return or of dying from the disease according to a new study published this week in the Journal of the American Medical Association. Researchers followed nearly 1,100 patients with stage III colon cancer who were being treated…  Read More